SAN DIEGO, Oct. 16, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at the Cannabis World Congress and Business Expo, taking place in Boston from Oct. 17-20. Medical Marijuana, Inc. CEO Dr. Stuart Titus will also be speaking on an expert panel at the conference discussing the evidence for medical cannabis.
“As cannabis research continues to flourish in the United States and throughout the world, I am proud to be at the forefront of this conversation and help people understand the many intricate facets of the industry,” Titus said. “We are proud to be a part of this important event and help spread education on cannabis and CBD.”
The Cannabis World Congress and Business Expo is held three times a year in the largest media, financial and business markets: Los Angeles, New York and Boston. CBD will be a major topic at this year’s conference in Boston as the U.S. Food and Drug Administration recently noted that CBD should not be a controlled substance and a new survey from the Brightfield Group predicted CBD sales will reach $22 billion by 2022, surpassing the rest of the cannabis market combined, if the Hemp Farming Act of 2018 (Farm Bill) is passed.
A panel at the conference, Medical Cannabis: Indications and Evidence, will feature Dr. Titus and Dr. Chanda Macias, exploring the evidence behind the therapeutic uses of cannabis and clinical studies that are currently in progress throughout the world. The panel will be on Thursday, Oct. 18, from 1:00-1:50 p.m. in Room 110.
Dr. Titus will be also be at HempMeds® Booth #208 educating conference attendees about the company’s unique CBD hemp oil products, including the award-winning brands Dixie Botanicals®, Cannabis Beauty Defined® and Real Scientific Hemp Oil™.
The Cannabis World Congress and Business Expo exhibit hall will be open from 11 a.m. to 5 p.m. on Thursday, Oct. 18, and Friday, Oct. 19, and from 10 a.m. to 4 p.m. on Saturday, Oct. 20.
For more information on the company, stop by HempMeds® Booth #208 or visit https://hempmedspx.com/.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media
P. 888-829- 0070